MedTrace Logo

Effect of a Self-adhering Material in Dental Hypersensitivity

NCT02766127 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2017-03-24

No results posted yet for this study

Summary

Aim: To compare the desensitizing capacity of Vertise Flow™ (VF), a new self adhering material, in the treatment of dentine hypersensitivity (DH) in patients who are xerostomic due to radiotherapy for head and neck cancer.

Methods: A total of 17 patients were selected for the study. The study was conducted as a split-mouth randomized clinical trial comparing: 1) VF 2) Universal Dentin Sealant (UDS), 3) Clearfil Protect Bond (CPB) and 4) Flor-Opal® Varnish (FOV). Basal and stimulated salivary flow was recorded for each patient according to the method described by Sreebny. The pain experience was generated by a cold stimulus directly to a sensitive tooth surface and assessed using the Visual Analogue Scale (VAS). The response was recorded before the application of the materials (PRE-1), immediately after (POST-1), at 1-week (POST-2), 4-weeks (POST-3) and 12-week controls (POST-4).

Conditions

  • Dentin Sensitivity
  • Xerostomia

Interventions

OTHER

Veritise Flow

Self-adhering composite

OTHER

Universal Dentin Sealant

non-polymerizable, high molecular weight resin sealant

OTHER

Clearfil Protect Bond

methacrylate-based resin, self-etching adhesive system

OTHER

Flor-Opal® Varnish

fluoride-based varnish

Sponsors & Collaborators

  • Università degli Studi di Sassari

    lead OTHER

Principal Investigators

  • Egle Milia, Prof · Università degli Studi di Sassari

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2014-06-30
Completion
2015-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02766127 on ClinicalTrials.gov